FIVE BELOW (FIVE) Fundamental Analysis & Valuation

NASDAQ:FIVE • US33829M1018

Current stock price

234.01 USD
-4.19 (-1.76%)
At close:
234.01 USD
0 (0%)
After Hours:

This FIVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. FIVE Profitability Analysis

1.1 Basic Checks

  • FIVE had positive earnings in the past year.
  • FIVE had a positive operating cash flow in the past year.
  • FIVE had positive earnings in each of the past 5 years.
  • Each year in the past 5 years FIVE had a positive operating cash flow.
FIVE Yearly Net Income VS EBIT VS OCF VS FCFFIVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 200M 400M

1.2 Ratios

  • FIVE has a better Return On Assets (7.26%) than 79.67% of its industry peers.
  • Looking at the Return On Equity, with a value of 16.35%, FIVE is in the better half of the industry, outperforming 75.61% of the companies in the same industry.
  • FIVE has a better Return On Invested Capital (8.59%) than 74.80% of its industry peers.
  • FIVE had an Average Return On Invested Capital over the past 3 years of 8.16%. This is significantly below the industry average of 13.58%.
  • The last Return On Invested Capital (8.59%) for FIVE is above the 3 year average (8.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.26%
ROE 16.35%
ROIC 8.59%
ROA(3y)6.96%
ROA(5y)7.69%
ROE(3y)16.46%
ROE(5y)18.69%
ROIC(3y)8.16%
ROIC(5y)9.97%
FIVE Yearly ROA, ROE, ROICFIVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5 10 15 20

1.3 Margins

  • FIVE's Profit Margin of 7.53% is amongst the best of the industry. FIVE outperforms 85.37% of its industry peers.
  • In the last couple of years the Profit Margin of FIVE has grown nicely.
  • With an excellent Operating Margin value of 9.60%, FIVE belongs to the best of the industry, outperforming 83.74% of the companies in the same industry.
  • FIVE's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 35.99%, FIVE perfoms like the industry average, outperforming 48.78% of the companies in the same industry.
  • In the last couple of years the Gross Margin of FIVE has grown nicely.
Industry RankSector Rank
OM 9.6%
PM (TTM) 7.53%
GM 35.99%
OM growth 3Y-5.05%
OM growth 5Y2.7%
PM growth 3Y-3.97%
PM growth 5Y3.66%
GM growth 3Y0.35%
GM growth 5Y1.6%
FIVE Yearly Profit, Operating, Gross MarginsFIVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. FIVE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FIVE is destroying value.
  • FIVE has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, FIVE has less shares outstanding
  • There is no outstanding debt for FIVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FIVE Yearly Shares OutstandingFIVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
FIVE Yearly Total Debt VS Total AssetsFIVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B

2.2 Solvency

  • FIVE has an Altman-Z score of 4.95. This indicates that FIVE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.95, FIVE belongs to the top of the industry, outperforming 90.24% of the companies in the same industry.
  • FIVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.95
ROIC/WACC0.96
WACC8.98%
FIVE Yearly LT Debt VS Equity VS FCFFIVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 2.01 indicates that FIVE has no problem at all paying its short term obligations.
  • The Current ratio of FIVE (2.01) is better than 78.05% of its industry peers.
  • FIVE has a Quick Ratio of 1.12. This is a normal value and indicates that FIVE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of FIVE (1.12) is better than 74.80% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.12
FIVE Yearly Current Assets VS Current LiabilitesFIVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. FIVE Growth Analysis

3.1 Past

  • FIVE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.14%, which is quite impressive.
  • FIVE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.03% yearly.
  • FIVE shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.90%.
  • FIVE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.41% yearly.
EPS 1Y (TTM)32.14%
EPS 3Y12.4%
EPS 5Y25.03%
EPS Q2Q%23.85%
Revenue 1Y (TTM)22.9%
Revenue growth 3Y15.7%
Revenue growth 5Y19.41%
Sales Q2Q%24.27%

3.2 Future

  • FIVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.72% yearly.
  • Based on estimates for the next years, FIVE will show a quite strong growth in Revenue. The Revenue will grow by 14.03% on average per year.
EPS Next Y24.97%
EPS Next 2Y17.98%
EPS Next 3Y15.39%
EPS Next 5Y27.72%
Revenue Next Year12.83%
Revenue Next 2Y11.09%
Revenue Next 3Y10.8%
Revenue Next 5Y14.03%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FIVE Yearly Revenue VS EstimatesFIVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
FIVE Yearly EPS VS EstimatesFIVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

3

4. FIVE Valuation Analysis

4.1 Price/Earnings Ratio

  • FIVE is valuated quite expensively with a Price/Earnings ratio of 35.14.
  • FIVE's Price/Earnings is on the same level as the industry average.
  • FIVE is valuated rather expensively when we compare the Price/Earnings ratio to 27.47, which is the current average of the S&P500 Index.
  • The Price/Forward Earnings ratio is 28.12, which means the current valuation is very expensive for FIVE.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FIVE is on the same level as its industry peers.
  • When comparing the Price/Forward Earnings ratio of FIVE to the average of the S&P500 Index (22.62), we can say FIVE is valued slightly more expensively.
Industry RankSector Rank
PE 35.14
Fwd PE 28.12
FIVE Price Earnings VS Forward Price EarningsFIVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • FIVE's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as FIVE.
Industry RankSector Rank
P/FCF 31.4
EV/EBITDA 18.5
FIVE Per share dataFIVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • FIVE has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as FIVE's earnings are expected to grow with 15.39% in the coming years.
PEG (NY)1.41
PEG (5Y)1.4
EPS Next 2Y17.98%
EPS Next 3Y15.39%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FIVE Dividend Analysis

5.1 Amount

  • FIVE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FIVE Fundamentals: All Metrics, Ratios and Statistics

FIVE BELOW

NASDAQ:FIVE (4/24/2026, 4:48:19 PM)

After market: 234.01 0 (0%)

234.01

-4.19 (-1.76%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)03-18
Earnings (Next)06-02
Inst Owners105.72%
Inst Owner Change0.12%
Ins Owners0.85%
Ins Owner Change-4.17%
Market Cap12.93B
Revenue(TTM)4.76B
Net Income(TTM)358.64M
Analysts78.18
Price Target258.68 (10.54%)
Short Float %4.1%
Short Ratio2.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.92%
Min EPS beat(2)5.54%
Max EPS beat(2)174.29%
EPS beat(4)4
Avg EPS beat(4)53.03%
Min EPS beat(4)3.28%
Max EPS beat(4)174.29%
EPS beat(8)6
Avg EPS beat(8)43.85%
EPS beat(12)8
Avg EPS beat(12)29.81%
EPS beat(16)9
Avg EPS beat(16)27.97%
Revenue beat(2)1
Avg Revenue beat(2)1.63%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)3.87%
Revenue beat(4)2
Avg Revenue beat(4)0.77%
Min Revenue beat(4)-1.55%
Max Revenue beat(4)3.87%
Revenue beat(8)3
Avg Revenue beat(8)-0.01%
Revenue beat(12)3
Avg Revenue beat(12)-0.64%
Revenue beat(16)4
Avg Revenue beat(16)-0.77%
PT rev (1m)16.96%
PT rev (3m)26.58%
EPS NQ rev (1m)80.71%
EPS NQ rev (3m)93.64%
EPS NY rev (1m)17.58%
EPS NY rev (3m)29.33%
Revenue NQ rev (1m)9.12%
Revenue NQ rev (3m)10.31%
Revenue NY rev (1m)1.91%
Revenue NY rev (3m)3.99%
Valuation
Industry RankSector Rank
PE 35.14
Fwd PE 28.12
P/S 2.71
P/FCF 31.4
P/OCF 22.04
P/B 5.89
P/tB 5.89
EV/EBITDA 18.5
EPS(TTM)6.66
EY2.85%
EPS(NY)8.32
Fwd EY3.56%
FCF(TTM)7.45
FCFY3.18%
OCF(TTM)10.62
OCFY4.54%
SpS86.24
BVpS39.7
TBVpS39.7
PEG (NY)1.41
PEG (5Y)1.4
Graham Number77.1347 (-67.04%)
Profitability
Industry RankSector Rank
ROA 7.26%
ROE 16.35%
ROCE 11.48%
ROIC 8.59%
ROICexc 11.21%
ROICexgc 11.21%
OM 9.6%
PM (TTM) 7.53%
GM 35.99%
FCFM 8.64%
ROA(3y)6.96%
ROA(5y)7.69%
ROE(3y)16.46%
ROE(5y)18.69%
ROIC(3y)8.16%
ROIC(5y)9.97%
ROICexc(3y)9.94%
ROICexc(5y)11.92%
ROICexgc(3y)9.94%
ROICexgc(5y)11.92%
ROCE(3y)10.91%
ROCE(5y)13.33%
ROICexgc growth 3Y0.32%
ROICexgc growth 5Y5.96%
ROICexc growth 3Y0.32%
ROICexc growth 5Y5.96%
OM growth 3Y-5.05%
OM growth 5Y2.7%
PM growth 3Y-3.97%
PM growth 5Y3.66%
GM growth 3Y0.35%
GM growth 5Y1.6%
F-Score9
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 90.95%
Cap/Sales 3.67%
Interest Coverage 962.95
Cash Conversion 90.29%
Profit Quality 114.79%
Current Ratio 2.01
Quick Ratio 1.12
Altman-Z 4.95
F-Score9
WACC8.98%
ROIC/WACC0.96
Cap/Depr(3y)180.23%
Cap/Depr(5y)223.84%
Cap/Sales(3y)7.15%
Cap/Sales(5y)7.95%
Profit Quality(3y)70.5%
Profit Quality(5y)49.96%
High Growth Momentum
Growth
EPS 1Y (TTM)32.14%
EPS 3Y12.4%
EPS 5Y25.03%
EPS Q2Q%23.85%
EPS Next Y24.97%
EPS Next 2Y17.98%
EPS Next 3Y15.39%
EPS Next 5Y27.72%
Revenue 1Y (TTM)22.9%
Revenue growth 3Y15.7%
Revenue growth 5Y19.41%
Sales Q2Q%24.27%
Revenue Next Year12.83%
Revenue Next 2Y11.09%
Revenue Next 3Y10.8%
Revenue Next 5Y14.03%
EBIT growth 1Y41.25%
EBIT growth 3Y9.86%
EBIT growth 5Y22.64%
EBIT Next Year80.14%
EBIT Next 3Y30.62%
EBIT Next 5Y26.41%
FCF growth 1Y286%
FCF growth 3Y87.06%
FCF growth 5Y19.95%
OCF growth 1Y36.17%
OCF growth 3Y23.03%
OCF growth 5Y9.89%

FIVE BELOW / FIVE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of FIVE BELOW (FIVE) stock?

ChartMill assigns a fundamental rating of 7 / 10 to FIVE.


What is the valuation status of FIVE BELOW (FIVE) stock?

ChartMill assigns a valuation rating of 3 / 10 to FIVE BELOW (FIVE). This can be considered as Overvalued.


What is the profitability of FIVE stock?

FIVE BELOW (FIVE) has a profitability rating of 8 / 10.


Can you provide the financial health for FIVE stock?

The financial health rating of FIVE BELOW (FIVE) is 8 / 10.


Can you provide the dividend sustainability for FIVE stock?

The dividend rating of FIVE BELOW (FIVE) is 0 / 10 and the dividend payout ratio is 0%.